Safety, Tolerability, and Pharmacokinetic Study of ISIS ApoC-III Rx in Hypertriglyceridemia
Clinical trial NCT01529424 · COMPLETED
Trial details
- NCT number
- NCT01529424
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2014-01-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.